ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
Dow Jones
42.297,12
0,86%
Euro vs US Dollar
1,0216
-0,27%
Bitcoin
93.624,42
-0,91%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Europa
  5. EU

  6. Celyad Oncology SA (CYAD) Börsenkurse

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0,521
0,001
(0,19%)
Geschlossen 13 Januar 5:30PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,521
Gebot
0,52
Fragen
0,54
Volumen
33.064
0,518 Tagesbereich 0,57
0,212 52-Wochen-Bereich 1,22
Marktkapitalisierung
21,585M
Handelsende
0,52
Handelsbeginn
0,549
Letzte Trade
142
@
0.521
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
103.236
Ausgegebene Aktien
41.429.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,55
Gewinn pro Aktie (EPS)
-0,2
Erlöse
102k
Nettogewinn
-8,45M

Über Celyad Oncology SA

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.celyad.com
Hauptsitz
Mont-saint-guibert, Walloon Brabant, Bel
Gegründet
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0,52 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0,212 € to 1,22 €.

Celyad Oncology currently has 41.429.000 shares in issue. The market capitalisation of Celyad Oncology is 21,54 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -2.55.

CYAD Neueste Nachrichten

Weitere Nachrichten

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

07 Oktober 2024
Business Wire

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

08 Februar 2024
GlobeNewswire Inc.

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

16 Januar 2024
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

20 Dezember 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

15 Dezember 2023
GlobeNewswire Inc.

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

04 Dezember 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

01 Dezember 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

21 November 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

14 November 2023
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.161-23.60703812320.6820.6830.518459060.58806722DE
4-0.229-30.53333333330.750.820.518379080.66521914DE
120.2675105.5226824460.25351.220.25251032360.73360994DE
260.262101.1583011580.2591.220.212556660.64787151DE
520.15140.81081081080.371.220.212374940.57016707DE
156-3.104-85.62758620693.6253.6250.212391091.08510312DE
260-9.979-95.038095238110.512.080.212416793.38438097DE

CYAD - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology share price?
The current share price of Celyad Oncology is 0,521 €
How many Celyad Oncology shares are in issue?
Celyad Oncology has 41.429.000 shares in issue
What is the market cap of Celyad Oncology?
The market capitalisation of Celyad Oncology is EUR 21,54M
What is the 1 year trading range for Celyad Oncology share price?
Celyad Oncology has traded in the range of 0,212 € to 1,22 € during the past year
What is the PE ratio of Celyad Oncology?
The price to earnings ratio of Celyad Oncology is -2,55
What is the cash to sales ratio of Celyad Oncology?
The cash to sales ratio of Celyad Oncology is 208
What is the reporting currency for Celyad Oncology?
Celyad Oncology reports financial results in EUR
What is the latest annual turnover for Celyad Oncology?
The latest annual turnover of Celyad Oncology is EUR 102k
What is the latest annual profit for Celyad Oncology?
The latest annual profit of Celyad Oncology is EUR -8,45M
What is the registered address of Celyad Oncology?
The registered address for Celyad Oncology is AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435
What is the Celyad Oncology website address?
The website address for Celyad Oncology is www.celyad.com
Which industry sector does Celyad Oncology operate in?
Celyad Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HYPDSHipay Group DS
0,0024 €
(200,00%)
1,83k
ALCYBCybergun
0,0002 €
(100,00%)
16,61M
BNBSTonner Drones
0,0015 €
(50,00%)
100
ALLPLLepermislibre SA
0,60 €
(50,00%)
27,77k
ALVGVEOM Group
0,16 €
(22,14%)
87,97k
ALTHETheraclion
0,23 €
(-17,86%)
34,88k
MLPACPacte Novation
8,35 €
(-14,80%)
3
ALALOAcheterLouerFR
0,0958 €
(-12,91%)
121,44k
MLVIRVirtualware 2007 SA
7,40 €
(-11,90%)
150
MLBONBonyf NV
15,90 €
(-11,67%)
105
ATOAtos SE
0,0022 €
(10,00%)
2,22B
BCPBanco Comercial Portugues SA
0,4802 €
(0,00%)
49,83M
ALVERVergnet
0,0017 €
(-5,56%)
18,84M
ALCYBCybergun
0,0002 €
(100,00%)
16,61M
INGAING Groep NV
15,538 €
(3,17%)
14,34M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten